Besides VEGF-A, the higher levels of VEGF-R1 in the AMD and RVO groups report of previous and identified VEGF-R1 could be a candidate molecular target whose suppression could supplement VEGF neutralization for treatment of RVO and AMD (37, 38). Here, FLT1 is linked to age-related macular degeneration.